Prot# TH-CR-406/SARC021: A Randomized Phase 3, Multicenter, Open-Label Study Comparing TH-302 in Combination with Doxorubicin vs. Doxorubicin Alone in Subjects with Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma

  • Agulnik, Mark (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date6/1/126/1/18

Funding

  • Parexel (Prot# TH-CR-406/SARC021)
  • Threshold Pharmaceuticals, Inc. (Prot# TH-CR-406/SARC021)